サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1676133

ホルモン補充療法の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測 （2025年～2033年）

Global Hormone Replacement Therapy Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 130 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
ホルモン補充療法の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測 （2025年～2033年）
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 130 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ホルモン補充療法の世界市場規模は、2024年の281億4,000万米ドルから2033年には484億4,000万米ドルに成長し、2026年から2033年の予測期間中に6.22％の堅調な年間平均成長率（CAGR）を示すと予測されます。

ホルモン補充療法（HRT）市場は、ホルモンバランスの乱れや更年期障害に関連する症状に対する効果的な治療法の需要が高まるにつれ、大きな成長を遂げています。HRTは、更年期を迎えた女性のほてり、寝汗、気分の落ち込みなどの症状を緩和するほか、男女ともにホルモン不足に対処するために広く使用されています。HRTの利点に対する意識の高まりは、人口の高齢化と相まって、ホルモン補充療法の需要を牽引しています。ヘルスケアプロバイダーがホルモンの変化を経験する患者の生活の質を改善しようとしているため、HRTの市場は繁栄すると予想されます。

技術の進歩は、ホルモン補充療法市場の将来を形作る上で重要な役割を果たしています。ドラッグ製剤、デリバリーシステム、個別化医療における革新は、HRTの有効性と安全性を高めています。例えば、バイオアイデンティカルホルモンや経皮デリバリーシステムの開発は、患者に個々のニーズに沿った治療の選択肢を提供しています。メーカーが研究開発への投資を続けているため、ホルモン補充療法市場はさまざまなヘルスケア環境での採用が増加するとみられます。

さらに、患者の教育と意識向上が重視されるようになっていることも、ホルモン補充療法市場の成長軌道に影響を与えています。患者が自分の健康状態や治療の選択肢について知識を深めるにつれて、患者固有のニーズに合わせたHRTソリューションに対する需要が高まっています。この動向は、患者がホルモンの健康について十分な情報を得た上で意思決定できるようにするための教育資源や支援システムを開発するために、ヘルスケアプロバイダーと製薬会社の協力を促しています。市場が進化し続ける中、テクノロジー、患者参加、個別化ケアの統合が成功の鍵となるでしょう。

当社のレポートは、様々な業界や市場に関する包括的かつ実用的な洞察をお客様に提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます：

市場概要：市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクション。

市場促進要因：市場成長に影響を与える主な促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 ホルモン補充療法産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 ホルモン補充療法の世界市場分析：治療タイプ別

  • 概要：治療タイプ別
  • 実績および予測データ分析：治療タイプ別
  • エストロゲン補充療法
  • ヒト成長ホルモン補充療法
  • 甲状腺ホルモン補充療法
  • 男性ホルモン補充療法
  • その他

第6章 ホルモン補充療法の世界市場分析：投与経路別

  • 概要：投与経路別
  • 実績および予測データ分析：投与経路別
  • 経口
  • 非経口
  • 経皮
  • その他

第7章 ホルモン補充療法の世界市場分析：用途別

  • 概要：用途別
  • 実績および予測データ分析：用途別
  • 更年期障害
  • 甲状腺機能低下症
  • 成長ホルモン欠乏症
  • 男性性腺機能低下症
  • その他

第8章 ホルモン補充療法の世界市場分析：流通チャネル別

  • 概要：流通チャネル別
  • 実績および予測データ分析：流通チャネル別
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第9章 ホルモン補充療法の世界市場分析：地域別

  • 地域別の展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋の売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカの売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第10章 ホルモン補充療法企業の競合情勢

  • ホルモン補充療法市場の競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品発売
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Pfizer Inc.
  • AbbVie Inc.
  • Bayer AG
  • Novo Nordisk A/S
  • Merck KGaA
  • Novartis AG
  • Eli Lilly And Company
  • Amgen Inc.
  • Sanofi S.A.
  • GlaxoSmithKline Plc
  • Endo International Plc
  • Allergan Plc
  • F. Hoffmann-La Roche AG
  • Ipsen Pharma
  • AstraZeneca Plc
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Therapy Type (USD MN)
  • Estrogen Replacement Therapy Market Sales By Geography (USD MN)
  • Human Growth Hormone Replacement Market Sales By Geography (USD MN)
  • Thyroid Hormone Replacement Market Sales By Geography (USD MN)
  • Testosterone Replacement Therapy Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Route of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Parenteral Market Sales By Geography (USD MN)
  • Transdermal Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Menopause Market Sales By Geography (USD MN)
  • Hypothyroidism Market Sales By Geography (USD MN)
  • Growth Hormone Deficiency Market Sales By Geography (USD MN)
  • Male Hypogonadism Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Hormone Replacement Therapy Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Hormone Replacement Therapy Report
  • Market Research Process
  • Market Research Methodology
  • Global Hormone Replacement Therapy Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Therapy Type
  • Market Attractiveness Analysis By Route of Administration
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Therapy Type (USD MN)
  • Estrogen Replacement Therapy Market Sales By Geography (USD MN)
  • Human Growth Hormone Replacement Market Sales By Geography (USD MN)
  • Thyroid Hormone Replacement Market Sales By Geography (USD MN)
  • Testosterone Replacement Therapy Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Route of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Parenteral Market Sales By Geography (USD MN)
  • Transdermal Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Menopause Market Sales By Geography (USD MN)
  • Hypothyroidism Market Sales By Geography (USD MN)
  • Growth Hormone Deficiency Market Sales By Geography (USD MN)
  • Male Hypogonadism Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11218811

Global Hormone Replacement Therapy Market size is anticipated to grow from USD 28.14 Billion in 2024 to USD 48.44 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 6.22% during the forecast period of 2026 to 2033.

The Hormone Replacement Therapy (HRT) Market is experiencing significant growth as the demand for effective treatments for hormonal imbalances and menopause-related symptoms increases. HRT is widely used to alleviate symptoms such as hot flashes, night sweats, and mood swings in women undergoing menopause, as well as to address hormonal deficiencies in both men and women. The rising awareness of the benefits of HRT, coupled with an aging population, is driving the demand for hormone replacement therapies. As healthcare providers seek to improve the quality of life for patients experiencing hormonal changes, the market for HRT is expected to flourish.

Technological advancements are playing a crucial role in shaping the future of the hormone replacement therapy market. Innovations in drug formulation, delivery systems, and personalized medicine are enhancing the effectiveness and safety of HRT. For instance, the development of bioidentical hormones and transdermal delivery systems is providing patients with more options for treatment that align with their individual needs. As manufacturers continue to invest in research and development, the hormone replacement therapy market is likely to see increased adoption across various healthcare settings.

Moreover, the growing emphasis on patient education and awareness is influencing the hormone replacement therapy market's growth trajectory. As patients become more informed about their health and treatment options, there is a rising demand for HRT solutions that are tailored to their specific needs. This trend is driving collaboration between healthcare providers and pharmaceutical companies to develop educational resources and support systems that empower patients to make informed decisions about their hormone health. As the market continues to evolve, the integration of technology, patient engagement, and personalized care will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Therapy Type

  • Estrogen Replacement Therapy
  • Human Growth Hormone Replacement
  • Thyroid Hormone Replacement
  • Testosterone Replacement Therapy
  • Others

By Route of Administration

  • Oral
  • Parenteral
  • Transdermal
  • Others

By Application

  • Menopause
  • Hypothyroidism
  • Growth Hormone Deficiency
  • Male Hypogonadism
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • COMPANIES PROFILED
  • Pfizer Inc.
  • AbbVie Inc.
  • Bayer AG
  • Novo Nordisk A/S
  • Merck KGaA
  • Novartis AG
  • Eli Lilly and Company
  • Amgen Inc.
  • Sanofi S.A.
  • GlaxoSmithKline plc
  • Endo International plc
  • Allergan plc
  • F. Hoffmann-La Roche AG
  • Ipsen Pharma
  • AstraZeneca plc.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. HORMONE REPLACEMENT THERAPY INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Therapy Type
    • 3.7.2 Market Attractiveness Analysis By Route of Administration
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL HORMONE REPLACEMENT THERAPY MARKET ANALYSIS BY THERAPY TYPE

  • 5.1. Overview By Therapy Type
  • 5.2. Historical and Forecast Data Analysis By Therapy Type
  • 5.3. Estrogen Replacement Therapy Historic and Forecast Sales By Regions
  • 5.4. Human Growth Hormone Replacement Historic and Forecast Sales By Regions
  • 5.5. Thyroid Hormone Replacement Historic and Forecast Sales By Regions
  • 5.6. Testosterone Replacement Therapy Historic and Forecast Sales By Regions
  • 5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL HORMONE REPLACEMENT THERAPY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 6.1. Overview By Route of Administration
  • 6.2. Historical and Forecast Data Analysis By Route of Administration
  • 6.3. Oral Historic and Forecast Sales By Regions
  • 6.4. Parenteral Historic and Forecast Sales By Regions
  • 6.5. Transdermal Historic and Forecast Sales By Regions
  • 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL HORMONE REPLACEMENT THERAPY MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Menopause Historic and Forecast Sales By Regions
  • 7.4. Hypothyroidism Historic and Forecast Sales By Regions
  • 7.5. Growth Hormone Deficiency Historic and Forecast Sales By Regions
  • 7.6. Male Hypogonadism Historic and Forecast Sales By Regions
  • 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL HORMONE REPLACEMENT THERAPY MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1. Overview By Distribution Channel
  • 8.2. Historical and Forecast Data Analysis By Distribution Channel
  • 8.3. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 8.4. Retail Pharmacies Historic and Forecast Sales By Regions
  • 8.5. Online Pharmacies Historic and Forecast Sales By Regions

9. GLOBAL HORMONE REPLACEMENT THERAPY MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE HORMONE REPLACEMENT THERAPY COMPANIES

  • 10.1. Hormone Replacement Therapy Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF HORMONE REPLACEMENT THERAPY INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Pfizer Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. AbbVie Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Bayer AG
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Novo Nordisk A/S
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Merck KGaA
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Novartis AG
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Eli Lilly And Company
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Amgen Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Sanofi S.A.
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. GlaxoSmithKline Plc
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Endo International Plc
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Allergan Plc
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. F. Hoffmann-La Roche AG
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments
  • 11.16. Ipsen Pharma
    • 11.16.1 Company Overview
    • 11.16.2 Company Revenue
    • 11.16.3 Products
    • 11.16.4 Recent Developments
  • 11.17. AstraZeneca Plc
    • 11.17.1 Company Overview
    • 11.17.2 Company Revenue
    • 11.17.3 Products
    • 11.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies